Journal
Proceedings of the National Academy of Sciences of the United States of America
Publication Date
10-26-2021
Volume
118
Issue
43
First Page
e2108728118
Document Type
Open Access Publication
DOI
10.1073/pnas.2108728118
Rights and Permissions
Matthew Mahoney, Vishnu C. Damalanka, Michael A. Tartell, Dong hee Chung, André Luiz Lourenço, Dustin Pwee, Anne E. Mayer Bridwell, Markus Hoffmann, Jorine Voss, Partha Karmakar, Nurit P. Azouz, Andrea M. Klingler, Paul W. Rothlauf, Cassandra E. Thompson, Melody Lee, Lidija Klampfer, Christina L. Stallings, Marc E. Rothenberg, Stefan Pöhlmann, Sean P. J. Whelan, Anthony J. O’Donoghue, Charles S. Craik, James W. Janetka (2021) A novel class of TMPRSS2 inhibitors potently block SARS-CoV-2 and MERS-CoV viral entry and protect human epithelial lung cells. Proceedings of the National Academy of Sciences, 118 (43): e2108728118. DOI: 10.1073/pnas.2108728118. This open access article is distributed under Creative Commons Attribution License 4.0 (CC BY).
Recommended Citation
Mahoney, Matthew; Damalanka, Vishnu C; Tartell, Michael A; Mayer Bridwell, Anne E; Voss, Jorine; Karmakar, Partha; Rothlauf, Paul W; Thompson, Cassandra E; Stallings, Christina L; Whelan, Sean P J; Janetka, James W; and et al, "A novel class of TMPRSS2 inhibitors potently block SARS-CoV-2 and MERS-CoV viral entry and protect human epithelial lung cells." Proceedings of the National Academy of Sciences of the United States of America. 118, 43. e2108728118 (2021).
https://digitalcommons.wustl.edu/open_access_pubs/11016
Supplemental materials
